JPMORGAN CHASE & CO - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 177 filers reported holding COHERUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$20,121,978
-17.7%
5,380,208
-6.1%
0.00%
-33.3%
Q2 2023$24,462,481
-40.2%
5,728,918
-4.2%
0.00%
-40.0%
Q1 2023$40,920,000
+79328.5%
5,982,535
-8.0%
0.01%
-28.6%
Q4 2022$51,518
-99.9%
6,504,863
+6.2%
0.01%
-12.5%
Q3 2022$58,864,000
+25.4%
6,125,245
-5.6%
0.01%
+14.3%
Q2 2022$46,959,000
-44.7%
6,486,231
-1.4%
0.01%
-30.0%
Q1 2022$84,890,000
-20.5%
6,575,543
-1.7%
0.01%
-16.7%
Q4 2021$106,768,000
-7.3%
6,689,748
-6.7%
0.01%
-14.3%
Q3 2021$115,236,000
+36.7%
7,170,867
+17.7%
0.01%
+40.0%
Q2 2021$84,281,000
+11.0%
6,094,058
+17.3%
0.01%0.0%
Q1 2021$75,915,000
-11.8%
5,196,106
+4.9%
0.01%
-23.1%
Q4 2020$86,094,000
-3.2%
4,953,582
+4.7%
0.01%
-13.3%
Q3 2020$88,977,000
+9.8%
4,730,357
+4.2%
0.02%
-6.2%
Q2 2020$81,047,000
+21.2%
4,537,904
+10.0%
0.02%0.0%
Q1 2020$66,896,000
+7.5%
4,124,245
+19.3%
0.02%
+33.3%
Q4 2019$62,251,000
-16.3%
3,457,470
-5.9%
0.01%
-20.0%
Q3 2019$74,408,000
-18.8%
3,672,646
-13.9%
0.02%
-16.7%
Q2 2019$91,630,000
+41.6%
4,263,805
-10.1%
0.02%
+38.5%
Q1 2019$64,689,000
+91.5%
4,742,589
+27.1%
0.01%
+62.5%
Q4 2018$33,774,000
-6.5%
3,731,881
+70.5%
0.01%
+14.3%
Q3 2018$36,107,000
+15.5%
2,188,328
-2.0%
0.01%
+16.7%
Q2 2018$31,261,000
+38.3%
2,232,898
+9.2%
0.01%
+20.0%
Q1 2018$22,598,000
+33.4%
2,045,068
+6.3%
0.01%
+25.0%
Q4 2017$16,935,000
-28.4%
1,924,494
+9.9%
0.00%
-20.0%
Q3 2017$23,640,000
+18.4%
1,751,202
+25.8%
0.01%0.0%
Q2 2017$19,971,000
-42.1%
1,391,711
-14.6%
0.01%
-37.5%
Q1 2017$34,485,000
-21.7%
1,630,487
+4.2%
0.01%
-27.3%
Q4 2016$44,051,000
-14.8%
1,564,868
-19.0%
0.01%
-15.4%
Q3 2016$51,712,000
+63.1%
1,930,979
+2.9%
0.01%
+62.5%
Q2 2016$31,701,000
-29.7%
1,876,937
-11.6%
0.01%
-33.3%
Q1 2016$45,062,000
+18.5%
2,122,551
+28.2%
0.01%
+20.0%
Q4 2015$38,025,000
+38.0%
1,656,163
+20.5%
0.01%
+42.9%
Q3 2015$27,554,000
-37.5%
1,374,970
-9.8%
0.01%
-30.0%
Q2 2015$44,069,000
+12.2%
1,524,911
+18.7%
0.01%
+11.1%
Q1 2015$39,285,000
+227.3%
1,284,703
+74.7%
0.01%
+200.0%
Q4 2014$12,001,000735,3190.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 568,408$2,125,84618.08%
CM Management, LLC 548,000$2,049,5202.18%
AlphaCentric Advisors LLC 912,500$3,412,7501.94%
Knott David M Jr 630,000$2,3560.90%
COURAGE CAPITAL MANAGEMENT LLC 50,000$1870.63%
Bridge City Capital, LLC 276,224$1,033,0780.52%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$11,354,9240.40%
Ikarian Capital, LLC 865,787$3,238,0430.39%
Aristotle Capital Boston, LLC 2,342,977$8,762,7340.28%
TANG CAPITAL MANAGEMENT LLC 400,000$1,496,0000.21%
View complete list of COHERUS BIOSCIENCES INC shareholders